Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$58.19 - $91.37 $11.5 Million - $18.1 Million
-197,804 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$20.19 - $84.93 $3.99 Million - $16.8 Million
197,804 New
197,804 $16.8 Million
Q3 2019

Nov 14, 2019

SELL
$21.55 - $27.61 $1.29 Million - $1.66 Million
-60,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$15.96 - $23.8 $957,600 - $1.43 Million
60,000 New
60,000 $1.32 Million

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.3B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.